tiprankstipranks
Jaguar Animal Health (DE:1JAA)
FRANKFURT:1JAA

Jaguar Animal Health (1JAA) Stock Price & Analysis

0 Followers

1JAA Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.04 - €0.97
Previous Close€0.23
Volume174.35K
Average Volume (3M)106.51K
Market Cap
€58.00M
Enterprise Value€79.68M
Total Cash (Recent Filing)$8.63M
Total Debt (Recent Filing)$31.66M
Price to Earnings (P/E)N/A
Beta1.57
May 13, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding276,216,269
10 Day Avg. Volume46,554
30 Day Avg. Volume106,509
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-3.02
Price to Sales (P/S)19.57
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.21
Enterprise Value/Gross Profit8.02
Enterprise Value/Ebitda-2.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%0.06%99.94%
0.06% Other Institutional Investors
99.94% Public Companies and
Individual Investors

1JAA FAQ

What was Jaguar Animal Health’s price range in the past 12 months?
Jaguar Animal Health lowest stock price was €0.04 and its highest was €0.97 in the past 12 months.
    What is Jaguar Animal Health’s market cap?
    Currently, no data Available
    When is Jaguar Animal Health’s upcoming earnings report date?
    Jaguar Animal Health’s upcoming earnings report date is May 13, 2024 which is in 8 days.
      How were Jaguar Animal Health’s earnings last quarter?
      Jaguar Animal Health released its earnings results on Apr 01, 2024. The company reported €1.307 earnings per share for the quarter, beating the consensus estimate of -€0.028 by €1.335.
        Is Jaguar Animal Health overvalued?
        According to Wall Street analysts Jaguar Animal Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Jaguar Animal Health pay dividends?
          Jaguar Animal Health does not currently pay dividends.
          What is Jaguar Animal Health’s EPS estimate?
          Jaguar Animal Health’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Jaguar Animal Health have?
          Currently, no data Available
          What happened to Jaguar Animal Health’s price movement after its last earnings report?
          Jaguar Animal Health reported an EPS of €1.307 in its last earnings report, beating expectations of -€0.028. Following the earnings report the stock price went up 15.385%.
            Which hedge fund is a major shareholder of Jaguar Animal Health?
            Currently, no hedge funds are holding shares in DE:1JAA
            ---

            Jaguar Animal Health Stock Smart Score

            Company Description

            Jaguar Animal Health

            Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
            ---

            1JAA Earnings Call

            Q4 2024
            0:00 / 0:00
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Jaguar Animal Health
            Petmed Express
            Zoetis
            Idexx Laboratories
            Elanco Animal Health
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis